One dose of Zostavax^® is indicated for the prevention of shingles. It can be given to patients who have previously had shingles. 

Since 1 April 2018, one dose of Zostavax is funded for adults aged 65 years. A ‘catch-up’ programme is available for people aged from 66–80 years inclusively until 31 March 2020. Funded vaccine doses are only available through general practice.